ArticleBlood2019

IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia.

Annika Scheffold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.